PEDIATRIC DRUGS 期刊简介

PEDIATRIC DRUGS
英文简介:

Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of review and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents. The Journal includes:

-overviews of contentious or emerging issues.
-comprehensive narrative reviews of topics relating to the effective and safe management of drug therapy through all stages of pediatric development.
-practical reviews covering optimum drug management of specific clinical situations.
-systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
-Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in the pediatric population.
-original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Pediatric Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

中文简介:(来自Google、百度翻译)

儿科药物促进了对儿科药物治疗 (包括疫苗) 感兴趣的医疗保健专业人员药物治疗的各个方面的优化和进步。该计划的审查和原始研究文章为医疗保健决策者提供了与药物治疗相关的问题的临床适用知识在所有领域的新生儿和儿童和青少年的护理。该期刊包括:
-有争议或新出现的问题的概述。
-关于在儿科发展的所有阶段中有效和安全管理药物治疗的主题的全面叙述性评论。
-涵盖特定临床情况的最佳药物管理的实用评论。
-系统的整理经验证据以回答特定研究问题的评论,使用PRISMA声明概述的明确,系统的方法。
-Adis药物回顾了儿科人群中较新和已建立药物的特性和治疗中的位置。
-原始研究文章报告了精心设计的研究结果,与临床实践有很强的联系,例如临床药效学和药代动力学研究,临床试验,荟萃分析,结果研究以及药物经济学和药物流行病学研究。
其他数字功能 (包括动画摘要,视频摘要,幻灯片,音频幻灯片,教学视频,信息图表,播客和动画) 可以与文章一起发布; 这些旨在提高期刊内容的知名度,读者群和教育价值。此外,在儿科药物中发表的文章可能会附有简单的语言摘要,以帮助对该领域有一定了解但不深入的专业知识的读者了解重要的医学进展。

官方内部论文预审系统 :
1-3天杂志社编辑直接预审
预审通过后100%录用,3个月即可录用

微信扫码咨询

期刊ISSN
1174-5878
影响指数
2.992
最新CiteScore值
4.70 查看CiteScore评价数据
最新自引率
1.80%
期刊官方网址

hot

https://www.paper-med.com/?type=9
期刊加急投稿网址

hot

https://www.paper-med.com/paper/index.html?type=10
通讯地址
5 THE WAREHOUSE WAY, NORTHCOTE, NEW ZEALAND, AUCKLAND, 0627
偏重的研究方向(学科)
PEDIATRICS-PHARMACOLOGY & PHARMACY
出版周期
出版年份
1999
出版国家/地区
NEW ZEALAND
是否OA
No
SCI期刊coverage
Science Citation Index Expanded(科学引文索引扩展)
NCBI查询
PubMed Central (PMC)链接 全文检索(pubmed central)
PEDIATRIC DRUGS 期刊中科院JCR 评价数据
最新中科院JCR分区
大类(学科)
小类(学科)
综述期刊
医学
PEDIATRICS(儿科)3区 PHARMACOLOGY & PHARMACY(药学)4区
最新的影响因子
2.992
最新公布的期刊年发文量
年度总发文量 研究类文章占比
63 47.62%
总被引频次 55
影响因子趋势图
近年的影响因子趋势图(整体平稳趋势)
PEDIATRIC DRUGS 期刊CiteScore评价数据
最新CiteScore值
4.70
年文章数 63
SJR
0.750
SNIP
1.346
CiteScore排名
序号 类别(学科) 排名 百分位
1 Medicine Pediatrics, Perinatology and Child Health #35/294
2 Medicine Pharmacology (medical) #76/246
CiteScore趋势图
CiteScore趋势图
PEDIATRIC DRUGS 投稿经验(由下方点评分析获得,0人参与,838人阅读)
投稿录用比例: 较易
审稿速度: >12周,或约稿
分享者 点评内容
没有更多了~
Copyright © 2014-2019 晟斯医学 All Rights Reserved. 备案号:苏ICP备11037034号-5 版权所有:南京孜文信息咨询有限公司